TORRENT PHARMACEUTICALS
Back to Cashflow Statement
|
TORRENT PHARMACEUTICALS Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹-12,712 Cr | ₹-540 Cr | ₹-168 Cr | ₹-2,415 Cr | ₹-197 Cr |
What is the latest Cash Flow from Investing Activities ratio of TORRENT PHARMACEUTICALS ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2026 | ₹-12,712 Cr |
| Mar2025 | ₹-540 Cr |
| Mar2024 | ₹-168 Cr |
| Mar2023 | ₹-2,415 Cr |
| Mar2022 | ₹-197 Cr |
How is Cash Flow from Investing Activities of TORRENT PHARMACEUTICALS Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-12,712 Cr | Negative | |
| Mar2025 | ₹-540 Cr | Negative | |
| Mar2024 | ₹-168 Cr | Negative | |
| Mar2023 | ₹-2,415 Cr | Negative | |
| Mar2022 | ₹-197 Cr | - | |
Compare Cash Flow from Investing Activities of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹184,494.0 Cr | -2.6% | -2.3% | 37.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,634.0 Cr | -2.9% | -2.3% | 21.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹241,576.0 Cr | -1.6% | 9.8% | 51.8% | Stock Analytics | |
| CIPLA | ₹111,888.0 Cr | -2.2% | -6.1% | -12.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,322.1 Cr | -0.9% | -1.8% | -9.8% | Stock Analytics | |
| MANKIND PHARMA | ₹96,179.6 Cr | -2.9% | -4.2% | -6.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | -2.6% |
-2.3% |
37.5% |
| SENSEX | -1% |
-2.6% |
-4.1% |
You may also like the below Video Courses